期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy 被引量:21
1
作者 Yingqi Xing Zhen-Ni Guo +3 位作者 Shuo Yan Hang Jin Shouchun Wang Yi Yang 《Neuroscience Bulletin》 SCIE CAS CSCD 2014年第3期469-476,共8页
Previous studies have identified a diverse set of predisposing factors for the occurrence of hemorrhagic transformation (HT), but the independent clinical predictors of HT after intra- arterial thrombolysis have not... Previous studies have identified a diverse set of predisposing factors for the occurrence of hemorrhagic transformation (HT), but the independent clinical predictors of HT after intra- arterial thrombolysis have not been determined. In this retrospective study, we investigated the characteristics of patients with or without HT who had received intra-arterial thrombolysis therapy, using biochemical analysis, renal function test, routine blood test, blood lipid test, coagulation blood test, liver function test, random blood glucose test, time- window for intra-arterial thrombolysis, recanalization, National Institutes of Health Stroke Scale (NIHSS) score and systolic blood pressure before intra-artedal thrombolysis. The mortality rates were similar in the HT and non-HT groups (P = 0.944). In the single- factor analysis, patients with a higher globulin level (P 〈0.002), prothrombin time activity percentage (PTA; P = 0.026), and NIHSS score (P = 0.002), had a significantly increased risk of developing HT. In the multifactor logistic regression model involving globulin level, PTA, white blood cell count, and NIHSS score, the globulin level (P 〈0.001; OR, 1.185; 95% confidence interval [CI], 1.090-1.288), PTA (P = 0.018; OR, 1.016; 95% CI, 1.003-1.029), white blood cell count (P = 0.025; OR, 1.097; 95% CI, 1.012-1.190) and NIHSS score (P = 0.003; OR, 1.097; 95% CI, 1.031-1.166) were significantly increased in the HT group. The increase in globulin level is an independent risk factor for HT in patients receiving intra-arterial thrombolysis. The possible mechanisms may involve inflammatory cytokines, matrix metalloproteinase 9, and positive acute-phase reactants synthesized by the liver. 展开更多
关键词 hemorrhagic transformation intra-arterialthrombolysis GLOBULIN
原文传递
透明质酸酶治疗透明质酸动脉栓塞兔耳皮肤缺血性病变的疗效观察 被引量:2
2
作者 庄岩 刘春军 杨明勇 《组织工程与重建外科杂志》 2019年第6期403-407,421,共6页
目的验证血管内应用透明质酸酶(Hyaluronidase,HAase)治疗透明质酸(Hyaluronid acid,HA)动脉栓塞兔耳皮肤缺血性病变的效果,比较全身静脉溶栓和选择性动脉溶栓的疗效差异。方法新西兰大白兔25只,经耳郭后动脉注射20μL HA,制作单耳动脉... 目的验证血管内应用透明质酸酶(Hyaluronidase,HAase)治疗透明质酸(Hyaluronid acid,HA)动脉栓塞兔耳皮肤缺血性病变的效果,比较全身静脉溶栓和选择性动脉溶栓的疗效差异。方法新西兰大白兔25只,经耳郭后动脉注射20μL HA,制作单耳动脉栓塞皮肤缺血模型,分为5组(n=5):单纯栓塞对照组(Control组)、生理盐水静脉溶栓对照组(IVT-NaCl组)、HAase静脉溶栓治疗组(IVT-HAase组)、生理盐水选择性动脉溶栓对照组(IAT-NaCl组)、HAase选择性动脉溶栓治疗组(IAT-HAase组)。术后4 h、3 d、7 d行荧光造影检查。比较各组术后7 d皮瓣灌注面积差异。结果术后7 d时,IAT-HAase组皮瓣平均灌注面积百分比显著高于其他4组(P<0.05),其他4组结果两两相比均无明显差异(P>0.05)。结论HAase选择性动脉溶栓能够有效改善HA动脉栓塞引起的皮瓣缺血,增加组织灌注,缩小皮瓣坏死面积。HAase全身静脉溶栓的疗效有待进一步研究。 展开更多
关键词 透明质酸 动脉栓塞 透明质酸酶 静脉溶栓 选择性动脉溶栓
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部